Edition:
United States

Albany Molecular Research Inc (AMRI.O)

AMRI.O on Nasdaq

21.73USD
18 Aug 2017
Change (% chg)

$-0.01 (-0.05%)
Prev Close
$21.74
Open
$21.73
Day's High
$21.77
Day's Low
$21.72
Volume
684,509
Avg. Vol
1,193,077
52-wk High
$22.17
52-wk Low
$13.01

AMRI.O

Chart for AMRI.O

About

Albany Molecular Research, Inc. is a contract research and manufacturing company. The Company operates through Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP) and Fine Chemicals (FC) segments. The DDS segment includes activities, such as drug lead discovery, optimization, drug... (more)

Overall

Beta: 1.14
Market Cap(Mil.): $936.98
Shares Outstanding(Mil.): 43.12
Dividend: --
Yield (%): --

Financials

  AMRI.O Industry Sector
P/E (TTM): -- 78.89 32.56
EPS (TTM): -1.43 -- --
ROI: -8.83 2.83 14.89
ROE: -20.61 5.09 16.13

BRIEF-AMRI announces early termination of HSR waiting period for Carlyle Group, GTCR's proposed acquisition

* AMRI announces early termination of Hart-Scott-Rodino waiting period for the Carlyle Group and GTCR's proposed acquisition of AMRI

Jun 29 2017

GTCR, Carlyle to buy contract research firm Albany Molecular

Contract drug manufacturer and research company Albany Molecular Research Inc said on Tuesday it had agreed to be taken private by buyout firms Carlyle Group LP and GTCR LLC for about $922 million in cash.

Jun 06 2017

UPDATE 4-GTCR, Carlyle to buy contract research firm Albany Molecular

* Albany Molecular shares jump as much as 8.9 pct (Adds analyst comment)

Jun 06 2017

BRIEF-AMRI to be acquired by the Carlyle Group and GTCR

* AMRI signs definitive agreement to be acquired by the Carlyle Group and GTCR for $21.75 per share in cash

Jun 06 2017

GTCR, Carlyle to buy contract research firm Albany Molecular

June 6 Contract research company Albany Molecular Research Inc said on Tuesday it would be bought by private equity firms Carlyle Group LP and GTCR LLC for about $922 million in cash.

Jun 06 2017

Deals of the day-Mergers and acquisitions

June 5 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

Jun 05 2017

Exclusive: GTCR, Carlyle in talks to acquire Albany Molecular Research - sources

Buyout firms GTCR LLC and Carlyle Group LP are in talks to team up and jointly acquire U.S. contract drug manufacturer and researcher Albany Molecular Research Inc , people familiar with the matter said on Monday.

Jun 05 2017

BRIEF-Amri Q1 non-gaap earnings per share $0.13

* Albany Molecular Research Inc - company confirms 2017 financial guidance

May 09 2017

BRIEF-Albany Molecular Research enters into agreement with pharmaceutical group Ferrer, Accord Healthcare

* Albany Molecular Research Inc - entered into an agreement with pharmaceutical group Ferrer and Accord Healthcare, Inc.

Feb 21 2017

BRIEF-AMRI posts Q4 adj. earnings per share $0.34

* AMRI announces fourth quarter and full year 2016 results and provides 2017 outlook

Feb 21 2017

Earnings vs. Estimates